BIORA THERAPEUTICS, INC. 3 SEC Filings

Filed On	Filing
15 Nov 2021	Form 3: Mohanty Aditya P., Director No securities owned
05 Nov 2021	Form 3: Howe Jill Ann, Director No securities owned
06 Jul 2021	Form 3: Sarna Surbhi, Director No securities owned
15 Mar 2021	Form 3: Hashemi Hutan, Chief Compliance Officer Holds 11,173 shares of Common Stock
18 Jun 2020	Form 3: Gianakopoulos George, Senior Vice President of Sales Holds 23,499 shares of Common Stock
18 Jun 2020	Form 3: Neumann Clarke, General Counsel and Secretary Holds 34,154 shares of Common Stock
18 Jun 2020	Form 3: Seelye Troy, Chief Information Officer Holds 22,256 shares of Common Stock
18 Jun 2020	Form 3: Cooper Matthew T, Chief Scientific Officer Holds 44,178 shares of Common Stock
18 Jun 2020	Form 3: Shihabi Sami, Chief Commercial Officer Holds 40,374 shares of Common Stock
18 Jun 2020	Form 3: Silvestry Damon, Chief Operating Officer Holds 24,279 shares of Common Stock
18 Jun 2020	Form 3: Athyrium Capital Management, Lp, 10% owner and 7 others
18 Jun 2020	Form 3: Athyrium Opportunities Fund (A) Lp, 10% owner and 9 others
18 Jun 2020	Form 3: dEsparbes Eric, Chief Financial Officer Holds 64,377 shares of Common Stock
18 Jun 2020	Form 3: Powell Lynne, Director Holds 18,335 shares of Common Stock
18 Jun 2020	Form 3: Nussbaum Samuel R Md, Director Holds 18,335 shares of Common Stock
18 Jun 2020	Form 3: Kotzin Brian L., Director Holds 18,335 shares of Common Stock
18 Jun 2020	Form 3: Bigalke John T., Director Holds 18,335 shares of Common Stock
18 Jun 2020	Form 3: Alter Jeffrey D., Director Holds 18,335 shares of Common Stock
18 Jun 2020	Form 3: Stylli Harry, Director Holds 1,005,302 shares of Common Stock

Comments